50
Participants
Start Date
May 1, 2025
Primary Completion Date
December 15, 2027
Study Completion Date
December 15, 2027
CBD Oral Solution (eCBD system Target)
Participants receive orally 6 ml of CBD Oral Solution (100 mg / ml; 60 mg / kg; max 600 mg of CBD) followed by 6 ml of a placebo composed of the inactive ingredients of CBD Oral Solution 3 weeks later.
Placebo
Participants receive orally 6 ml of a placebo composed of the inactive ingredients of CBD Oral Solution followed by 6 ml of Oral CBD Solution (100 mg / ml; 60 mg / kg; max 600 mg of CBD)
Collaborators (1)
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Jazz Pharmaceuticals
INDUSTRY
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
OTHER
Université de Sherbrooke
OTHER